Biohit Oyj’s Financial Reporting and Annual General Meeting in 2022

Biohit Oyj Financial calendar, January 13, 2022 at 2:30 pm local time (EET) 

  • Biohit Oyj will release its financial statements for 2021 on Wednesday 16th of February 2022 at 9:30 am.  
  • The Annual Report, which contains the Financial Statements for 2021 and the Report of the Board of Directors, will be published on Wednesday 30th of March 2022 at 9:30.
  • Biohit Oyj’s Annual General Meeting has been planned for Wednesday 15th of June 2022 at 2:00 pm. The Board of Directors will call the General Meeting at a later date.
  • Half year financial report for period January-June (H1) 2022 will be published on Wednesday 10th of August 2022 at 9:30 am.

The published economic reports and other stock exchange releases are available on Biohit's website at www.biohithealthcare.com/investors. The website also contains an online form for ordering electronic copies, which will be e-mailed to you, available at http://www.biohithealthcare.com/investors/stock-exchange-releases/order-releases-to-your-email.

Additional information: 
CEO Päivi Siltala, Biohit Oyj
tel. +358 9 773 861
investor.relations@biohit.fi
www.biohithealthcare.com

Biohit in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit is headquartered in Helsinki, Finland, and has subsidiaries in Italy and the UK. Biohit's Series B share (BIOBV) is quoted on Nasdaq Helsinki in the Small cap/Healthcare group. www.biohithealthcare.com